Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Non-Current Debt (2020)

Lexaria Bioscience's Non-Current Debt history spans 1 years, with the latest figure at $30852.0 for Q4 2020.

  • For Q4 2020, Non-Current Debt changed N/A year-over-year to $30852.0; the TTM value through Nov 2020 reached $30852.0, changed N/A, while the annual FY2020 figure was $30670.0, N/A changed from the prior year.
  • Non-Current Debt for Q4 2020 was $30852.0 at Lexaria Bioscience, up from $30670.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $30852.0 in Q4 2020 and bottomed at $28756.0 in Q2 2020.